We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

34 hedge funds and large institutions have $1.97M invested in AIM ImmunoTech in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

13% more funds holding

Funds holding: 30 → 34 (+4)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

35% less capital invested

Capital invested by funds: $3.01M → $1.97M (-$1.04M)

Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$31.1K
2
VF
Virtu Financial
New York
+$17.9K
3
UBS Group
UBS Group
Switzerland
+$10.2K
4
Renaissance Technologies
Renaissance Technologies
New York
+$8.32K
5
HF
HRT Financial
New York
+$6.66K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$113K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$36.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$18.1K
4
DS
DRW Securities
Illinois
-$5.55K
5
Jane Street
Jane Street
New York
-$5.24K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$905K – – –
BlackRock
2
BlackRock
New York
$322K +$62 +1 +0%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$160K -$18.1K -293 -8%
Morgan Stanley
4
Morgan Stanley
New York
$115K -$113K -1,834 -42%
Renaissance Technologies
5
Renaissance Technologies
New York
$88K +$8.32K +135 +8%
State Street
6
State Street
Massachusetts
$78.8K – – –
Verition Fund Management
7
Verition Fund Management
Connecticut
$67.3K +$4.93K +80 +6%
BCM
8
Bridgeway Capital Management
Texas
$49.5K – – –
Northern Trust
9
Northern Trust
Illinois
$38.9K -$555 -9 -1%
TSS
10
Two Sigma Securities
New York
$27.6K +$31.1K +504 +489%
SWM
11
SeaCrest Wealth Management
New York
$16.9K – – –
DS
12
DRW Securities
Illinois
$13K -$5.55K -90 -24%
VF
13
Virtu Financial
New York
$13K +$17.9K +291 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$11.5K – – –
CAPTRUST Financial Advisors
15
CAPTRUST Financial Advisors
North Carolina
$9.1K – – –
FWM
16
ForthRight Wealth Management
Georgia
$9.1K – – –
UBS Group
17
UBS Group
Switzerland
$7.51K +$10.2K +165 New
Jane Street
18
Jane Street
New York
$6.23K -$5.24K -85 -38%
CB
19
Community Bank
New York
$5.95K – – –
DBRC
20
D.B. Root & Company
Pennsylvania
$5.48K – – –
TCM
21
Traynor Capital Management
Pennsylvania
$5.36K – – –
SFG
22
SNS Financial Group
Minnesota
$4.55K – – –
HF
23
HRT Financial
New York
$4K +$6.66K +108 New
VAG
24
VisionPoint Advisory Group
Texas
$1.43K +$1.91K +31 New
Osaic Holdings
25
Osaic Holdings
Arizona
$1.04K – – –
1
2

AIM Hedge Fund Activity: Q3 2023 in Review

34 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2023, worth a combined $1.97M — down 35% from $3.01M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AIM positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Two Sigma Securities, adding an estimated $31.1K. The largest seller was Morgan Stanley, cutting an estimated $113K.

  • 34 institutional investors held AIM ImmunoTech (AIM) as of Q3 2023, up from 30 in Q2 2023.
  • Funds reported $1.97M of AIM ImmunoTech stock for Q3 2023, down 35% quarter-over-quarter.
  • 7 funds opened new AIM ImmunoTech positions in Q3 2023 and 3 closed out, a net change of +4 holders.
  • The largest AIM ImmunoTech buyer in Q3 2023 was Two Sigma Securities, an estimated $31.1K added.
  • The largest AIM ImmunoTech seller in Q3 2023 was Morgan Stanley, an estimated $113K sold.

Based on aggregated 13F filings for Q3 2023.